Invenomic Capital Management LP
Top Portfolio Positions
146 positions ·
$2,186,520,646 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| CHRD |
Chord Energy Corp
Energy
|
515,084 | $73,234,643 | 3.35% | |
| WDAY |
Workday, Inc.
Technology
|
559,955 | $72,749,353 | 3.33% | |
| GPN |
Global Payments Inc
Industrials
|
914,505 | $61,546,186 | 2.81% | |
| PVH |
Pvh Corp. /De/
Consumer Cyclical
|
763,279 | $53,246,343 | 2.44% | |
| TFX |
Teleflex Inc
Healthcare
|
436,125 | $52,164,911 | 2.39% | |
| XRAY |
DENTSPLY SIRONA Inc.
Healthcare
|
4,390,093 | $50,925,078 | 2.33% | |
| EGO |
Eldorado Gold Corp /Fi
Basic Materials
|
1,433,874 | $49,224,894 | 2.25% | |
| FIS |
Fidelity National Information Services, Inc.
Technology
|
1,034,189 | $48,513,805 | 2.22% | |
| AKAM |
Akamai Technologies Inc
Technology
|
405,632 | $46,586,835 | 2.13% | |
| VTRS |
Viatris Inc
Healthcare
|
3,229,112 | $43,625,303 | 2.00% |
Portfolio Trend
25 quarters · across all stocks
Holdings in PENN
Shares Held
Position Value (USD)
11 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,217,848 | 1,544,767 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,642,031 | 1,535,053 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,237,025 | 1,569,939 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $26,249,439 | 1,468,911 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $30,322,116 | 1,859,112 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $19,617,142 | 989,765 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,641,661 | 1,147,490 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $26,510,654 | 1,369,352 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $34,312,811 | 1,884,284 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $28,526,142 | 1,096,316 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $44,941,745 | 1,958,246 | Shares | Sole | 2023-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||